Skip to main content
. 2015 Aug 23;2015:403576. doi: 10.1155/2015/403576

Figure 2.

Figure 2

Clinical impact of NR5A2 in two cohorts of infiltrating ductal breast carcinomas. ANOVA test results of NR5A2(16670) mRNA levels in eight clinical indices: progesterone receptor (PR), HER-2/neu (HER), lymphovascular invasion (LVI), lymph nodal category (lymph node metastasis status (LYM), number of lymph node metastases (LNM)), age, tumor size (size), histological grade (grade), nuclear pleomorphism (NP), mitotic count (MC), tubule formation (TF), and cancer stage in 91A cohort and 181A cohort, respectively (a, b). (c, d): box plot analysis of NR5A2(16670) mRNA levels in two cohorts (i.e., nontumor component (NT) and 181A cohort) (c). The number on the y-axis inside the box plot C stands for the expression level of NR5A2. The x-axis for each box stands for 25 nontumor (NT) and 181A cohorts, respectively. Box plot analysis for pairwise comparison of NR5A2(16670) mRNA levels and NR5A1(652) mRNA levels in three cohorts (i.e., 90A cohort, 91A cohort, and 181A cohort) (d). The number on the y-axis inside the box plot D stands for the expression level of the given TF which is listed in the x-axis, respectively. The red dot line within the box is the mean value for each subgroup in the plot. The black line within the box is the median value for each subgroup in the plot. The Agilent feature number for NR5A2 is 16670. 652 is the Agilent feature number for NR5A1.